FILE - This undated product image provided by Amgen Inc. shows the cholesterol drug Repatha. Amgen Inc. said Wednesday, Oct. 24, 2018, that it is immediately cutting the price of Repatha by 60 percent, from about $14,000 to $5,850 per year. (Robert Dawson/Amgen via AP, File)
Featured Photo Galleries
